If you need more lookups,
subscriptions start at $34 USD/month.
Karin Stebbins Location
San Clemente, CA, US
Karin Stebbins Work
VP of Toxicology @ (January 2024 - Present)
Sr. Director of Pharmacology @ Pipeline Therapeutics (Contineum Therapeutics) (January 2021 - January 2024)
Director of Pharmacology @ (March 2018 - January 2021)
Associate Director @ Inception Sciences (October 2015 - January 2018)
Assistant Director @ Inception Sciences (October 2012 - October 2015)
Senior Scientist @ Inception Sciences (January 2011 - October 2012)
Senior Scientist @ (July 2010 - November 2010)
Research Scientist @ (May 2008 - July 2010)
Scientist @ (July 2007 - April 2008)
Scientist II @ Organon Research Center USAS (January 2005 - January 2006)
Consulting Scientist @ (January 2005 - January 2005)
Sr Scientist II @ UCB Research (January 2000 - October 2004)
Sr Research Associate Scientist @ Ariad Pharmaceuticals (January 1993 - January 2000)
Karin Stebbins Education
McGill University
Bachelor of Science (BSc) (Physiology)
1989-1993
WLC 1983-1990
Karin Stebbins Skills
Allergy
Assay Development
Biotechnology
Clinical Development
Drug Development
Drug Discovery
Immunology
In Vivo
Inflammation
Life Sciences
Neurology
Oncology
Pharmaceutical Industry
Pharmacodynamics
Pharmacology
Research
Therapeutic Areas
PowerPoint
Science
Microsoft Office
Project Management
Strategy
Cell Culture
Karin Stebbins Summary
Karin Stebbins, based in San Clemente, CA, US, is currently a VP of Toxicology at Contineum Therapeutics. Karin Stebbins brings experience from previous roles at Pipeline Therapeutics (Contineum Therapeutics), Pipeline Therapeutics and Inception Sciences. Karin Stebbins holds a 1989 - 1993 Bachelor of Science (BSc) in Physiology @ McGill University. With a robust skill set that includes Allergy, Assay Development, Biotechnology, Clinical Development, Drug Development and more. Karin Stebbins has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Karin Stebbins?
Find contact details for 700 million professionals.